NCT02232256 2017-04-26
CALPXT96
9305-9954 Quebec Inc
Phase 3 Withdrawn
Clinical Trials
5 trialsNCT00943566 2015-09-15
A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer
Labtec GmbH
Phase 2 Withdrawn
NCT01374191 2015-08-26
Botulinum Toxin Type A for Neuroma Pain
Southern Illinois University
Phase 2 Withdrawn
NCT01206907 2012-08-17
Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects
Endo Pharmaceuticals
Phase 3 Withdrawn
NCT00306020 2012-07-04
Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain
Soroka University Medical Center
Phase NA Withdrawn